Isolation and Characterization of a Xenopus laevis C Protein cDNA: Structure and Expression of a Heterogeneous Nuclear Ribonucleoprotein Core Protein by Preugschat, Frank & Wold, Barbara J.
Proc. Nati. Acad. Sci. USA
Vol. 85, pp. 9669-9673, December 1988
Genetics
Isolation and characterization of a Xenopus laevis C protein cDNA:
Structure and expression of a heterogeneous nuclear
ribonucleoprotein core protein
FRANK PREUGSCHAT AND BARBARA WOLD*
Division of Biology, California Institute of Technology, Pasadena, CA 91125
Communicated by John Abelson, May 31, 1988
ABSTRACT The C proteins are major components of
heterogeneous nuclear ribonucleoprotein complexes in nuclei
of vertebrate cells. To begin to describe their structure,
expression, and function we isolated and determined the DNA
sequence ofXenopus laevis C protein cDNA clones. The protein
predicted from the DNA sequence has a molecular mass of
30,916 kDa and is very similar to its human counterpart.
Although mammalian genomes contain many copies of C
protein sequence, the Xenopus genome contains few copies.
When C protein RNA was synthesized in vitro and microin-
jected into stage-VI Xenopus oocytes, newly synthesized C
proteins were efficiently localized in the nucleus. In vitro rabbit
reticulocyte lysate and in vivo Xenopus oocyte translation
systems both produce from a single mRNA two discrete
polypeptide species that accumulate in a ratio similar to that of
mammalian C1 and C2 proteins in vivo.
Biogenesis ofmRNA in eukaryotes features a complex series
of posttranscriptional events. These include processing and
modification of primary transcripts to remove intervening
sequences and create 3' termini, selective degradation of a
large fraction of newly synthesized heterogeneous nuclear
RNA (hnRNA), and efficient translocation of mature mRNA
to the cytoplasm. These critical events in RNA metabolism
display high sequence specificity and can be regulated both
qualitatively and quantitatively to yield biologically signifi-
cant alterations in the pattern of gene expression. Several
diverse lines of evidence indicate that the substrates for
intranuclear RNA processing and transport are not naked
nucleic acids, but rather are ribonucleoprotein (RNP) com-
plexes. These nuclear RNP complexes are subsequently
dismantled in conjunction with export of RNA to the cyto-
plasm where messages are associated with a new set ofRNPs
(for reviews, see refs. 1 and 2).
The first RNP complexes to form on polymerase II tran-
scripts are referred to as heterogeneous nuclear RNPs
(hnRNPs) or ribonucleosomes, and they are assembled
cotranscriptionally. These have been visualized in striking
electron micrographs in which nascent transcripts are seen in
a pattern of 200-A RNP "beads on a string" (3-7). Limited
ribonuclease digestion of nuclear RNP yields a population of
relatively uniform stable monomers that sediment at 30-40S
under temperate salt and pH conditions (8-11). The protein
complement of a monoparticle preparation consists of a
discrete set of highly conserved polypeptides (1, 2, 9, 12, 13).
An alternative approach to defining proteins closely associ-
ated with RNA is to chemically or photochemically crosslink
them (14-17). The suite ofRNP proteins identified by in vivo
UV crosslinking displays remarkable overlap with the set
detected by extraction of nuclei and gradient fractionation,
although some species specific to each method of preparation
are also seen (for reviews, see refs. 1 and 2).
Among the hnRNP proteins defined by the above biochem-
ical criteria are the "core" ribonucleosome proteins. The
widely used nomenclature of LeStourgeon et al. (9) desig-
nates prominent core hnRNP components from human cells
in culture as A, B, and C proteins based on their migration
pattern in sodium dodecyl sulfate (SDS)/polyacrylamide
gels. It is thought that these proteins comprise a protein core
offixed stoichiometry with RNA wrapped around the outside
of the particle (1, 2, 12, 18, 19). The type C proteins are
especially tightly associated with RNA. They are, in com-
parison with the A and B proteins, the least sensitive to
dissociation from RNA at increasing salt concentrations (1, 9)
and are also among the most efficiently UV-crosslinked core
components (16, 17, 20). C proteins are of particular biolog-
ical interest because, in addition to their close physical
association with hnRNA, they have recently been shown to
be required for proper removal of intervening sequences in a
mammalian in vitro splicing system (21).
The assembly and fate of the core hnRNP is of interest
because it defines the first known posttranscriptional struc-
ture formed on the pathway leading to RNA maturation and
transport out of the nucleus. Oocytes of the frog Xenopus
laevis offer some special advantages for the study of RNA
processing (22-26) and transport (27-30). We therefore ini-
tiated detailed molecular characterization of key proteins
comprising the Xenopus nuclear hnRNP structure. In this
report we describe the isolation and characterization of
Xenopus C protein cDNAs and their RNA and protein
products.t
MATERIALS AND METHODS
DNA Sequence. A Xenopus Agtl0 ovary cDNA library (gift
of D. Melton) (31) was screened with 32P-labeled clone 4F4
human C protein cDNA insert (32). Hybridization criteria
were 550C in 5x SSPE (lx SSPE = 0.18 M NaCl/10 mM
phosphate, pH 7.4/1 mM EDTA) followed by washing at
550C with 2x SSPE. The sequence of pXEC1.3 was deter-
mined on both strands from overlapping clones by standard
techniques (33-35).
DNA and RNA Analysis. DNA was prepared from the blood
of a single female frog (36), and gel blots were performed on
Pall Biodyne membranes with uniformly 32P-labeled single-
strand probes of 109 dpm/,ug. RNA was prepared from
Xenopus liver, ovary, and A6 cultured cells essentially as
described (37) with the addition of pelleting through a CsCl
Abbreviations: RNP, ribonucleoprotein; hnRNA, heterogeneous
nuclear RNA; hnRNP, heterogeneous nuclear ribonucleoprotein;
SDS, sodium dodecyl sulfate; nt, nucleotide(s).
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GAATTCCGCCCCTCTAATCTCCGCGATAATC TAGCTCACAT AT T TATTTGAAGGT TAAAGGCCTCA TAACAAAACGAATGGCAAGGGCTCATGTCTATCACACAGACGCTGTTGTGAT TACTAGAAAGT TTCTGCAAGCGAAGAAT TTT TTT TGAAACTTCA 162
M M A S N V T N K T 0 P 9 S M N S R V F I G N L N T L V V K K T D V E A I F S K Y G K 43
ACTACCGCCA^AAT TGCGTCCCCTCAT TCCATCATGATGGCCAGTAATGTGACT AACAAGACGGATCCCCGT TCGATGAACTCGCGTGTAT TTAT TGGGAACCTTAATACGCT TGT TGT TAAGAAAACTGATGTAGAAGCAAT CT T TTCAAAATATGGAAAG 324
I V G C S V H K G F A F V 0 F S N E A T A R T A V A G E D G R M I A G G V L 0 I N L A A E P K A N R S K T G 97
AT TGTGGGCTGTTCTGTGCACAAGGGCT TTGCAT TTGTGCAGT T TTCCAATGAACGCACTGCCCGTACAGCCGT TGCAGGTGAAGATGGGCGCATGA TTGCAGGGCAAGTCCTGGAT ATCAATT TAGCTGCTGAACCTAAAGCAAACAGAAGCAAAACTGGT 486
V K R S A A V M Y G S S F V L E Y 0 F P R V Y Y S S Y S A T R V P A P P P L A R A V V P S K R 0 R V S G N A 151
GTCAAACGACAGCTGCAGACATGTATGGGTCTTCCTT TGATTTGGAGTATGATTTCCCAAGAGATTACTATGACAGCTATTCTGCAACACGT GT ACCAGCTCCl CCTCCATTAGCTCGGGCAGTAGTGCCATCAAAAAGGCAAAGAGTATCTGGAAATGCA 648
S A R G K S G F N S K S G 0 R G G S S K S S R L K G D D L 0 A I K K E L S 0 I K 0 R V D S L L E N L E R I E 205
TCTCGGCGTGGTAAGAGTGGCT T TAACTCAAAAAGT GGCCAGCGAGGTGGT TCCT CAAAA TC TAGT AGAT TGAAGGGAGA TGATCT TCAGGCAATCAAAAAGGAGCTCAGTCAGATAAAGCAGAGAGT AGAT TC TCTCT TGGAAAACCTAGAAAGGAT TGAG 810
R D 0 S K 0 D T K L 0 V D 0 S S V S L K K E E T G V K L I E E T G D S A E E G D L L D D D E 0 G E D T L E E 259
CGTGACCAGTCAAAACAAGATACCAAATTAGATGATGACCAAAGCAGCGT TTCT TTAAAGAAAGAGGAGACTGGTGT TAAGC TGAT AGAAGAAACAGGGGAT TCTGCAGAGGAAGGAGAC TTGCT TGATGA TGATGAACAGGGTGAAGACACGC TTGAAGAA 972
I K D G D K E T E E G E S E G D S A N E E D S 282
ATTAAAGATOGAGACAAAGAAACAGAAGAGGGAGAAGATGAAGGAGACAGCGC TAACGAGGAAGACTC T TAAA TTCAT TAACCT TTCA TGT AAC TCT TCA TCTGC TTGTCT T TCTGT C TTGTC TCA TAGCACC T TTC T TAACAGTCCCTCAATCCATCCGC T 1134
GCTTTAAGCTTGTTTAAATATGCACCCTCCTATCCCTCAGCCTCCATTTCATTTTGATACCTGTTTGCGACTTCTAGAATAAAAGTGTATTGT TTTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 1274
FiG. 1. Complete sequence of Xenopus C protein cDNA clone pXEC1.3 with translation of the major open reading frame.
cushion. Polyadenylylated RNA was selected by oligo(dT)-
cellulose chromatography, fractionated in formaldehyde/
agarose gels (38), transferred to filters, and hybridized as
described for DNA. For primer extension 10 pmol ofa primer
complementary to nucleotides 231-245 was 5'-end-labeled to
a specific activity of 109 dpm/,g using T4 polynucleotide
kinase and extended with avian myeloblastosis virus reverse
transcriptase at 42°C in 1 mM dNTPs with RNAsin at 0.5
units/Al The reaction mixture was phenol extracted. Mate-
rial excluded from G-50 Sephadex was analyzed by electro-
phoresis through a urea/polyacrylamide gel (36).
Translations. SP6 sense-strand RNA was transcribed from
Sal I-linearized pXEC1.3 or pXEC1.0 (39). RNA was capped
by inclusion of 2 mM bis(guanylyl)triphosphate (GpppG) in
the transcription reaction with GTP at 500 AM and the other
nucleotides at 2 mM. Purified RNA was suspended in water
at 1 mg/ml. Twenty nanoliters of RNA per oocyte were
injected, and they were incubated in OR2 buffer (82 mM
NaCl/2.5 mM KCI/1 mM MgCl2/1 mM CaCI2/10 mM
Hepes/1 mM NaH2PO4, pH 7.8) at 5°C for 30 min and then
at 22°C for 8 hr. [35S]Methionine was then added to a final
concentration of 0.5-1 mCi/ml (1 Ci = 37 GBq), and the
incubation was continued for 4-20 hr at room temperature.
Oocyte nuclei and cytoplasms were prepared by manual
dissection in J buffer (40) or by dissection after boiling for 1
min in OR2 buffer.
RESULTS AND DISCUSSION
Monoclonal antibodies specific for human C protein were
previously used to identify and isolate a cDNA clone for
human C protein (32). Here we used that 1.1-kilobase (kb)
human C protein cDNA to identify homologous sequences in
a library of cDNA clones prepared from Xenopus ovary
polyadenylylated RNA (31). Cloned cDNAs of 1.0- and
1.3-kb lengths derived from two independent phage were
subcloned, mapped, and sequenced. The 1274-nucleotide (nt)
sequence of Xenopus C protein clone pXEC1.3 is shown in
Fig. 1 together with the predicted amino acid sequence of the
single long open reading frame. The open reading frame is
preceded by a 195-nt 5'-untranslated segment that contains
stop codons in all reading frames. The presence of these
termination codons supports the assignment of Met-1 in Fig.
1 as the first possible initiation site for C protein synthesis.
The methionine codon at position 2 in the open reading frame
best conforms to the preferred consensus for translation
initiation (41). The open reading frame codes for a protein of
30,916 Da, although the protein products produced by tran-
scription and subsequent translation of the cloned sequence
migrate in SDS gels with apparent molecular masses of41 and
39 kDa (Fig. 3). The 3'-untranslated segment contains a single
copy of the consensus signal for terminal cleavage and
poly(A) addition, AATAAA (42), and a poly(A) tract that
begins 20 nt downstream.
To confirm that the Xenopus clones isolated in this report
are significantly similar to the human C probe, we determined
the DNA sequence corresponding to the first 77 amino acid
residues of the human clone. The DNA sequences display
83% identity and the protein sequences 92%, with all amino
acid substitutions being functionally conservative (data not
shown). While this work was in preparation the full human
sequence was reported (43), and the sequence similarity
extends throughout the protein coding sequence. The amino
acid composition and expected isoelectric point of the Xe-
nopus C protein deduced from our DNA sequence data agree
remarkably well with those determined empirically for mam-
malian C proteins (13), whereas there is little resemblance to
class A, B, or D RNP proteins. These data, taken together
with immunological definition of the human clone and its high
degree of similarity with the Xenopus open reading frame (17,
32), lead us to conclude that pXEC1.0 and 1.3 code for
Xenopus hnRNP C protein.
C Protein Expression. The pXEC1.3 cDNA clone was used
as a probe to identify C protein mRNA on RNA gel blots. A
single size species of 1.3 ± 0.1 kb was detected in poly-
adenylylated RNA ofA6 cells in culture (Fig. 2A), adult liver,
or defolliculated oocytes (data not shown). The quantities of
C protein RNA in stage V-VI oocytes and embryos at
gastrula and neurula stages are all similar-about 1 x 106
transcripts per oocyte or embryo (R. Wagner, personal
A
1 2
13 kb- g
RNA gel
Blot
B
1 2
31
ad
:..
A.
-
278 - _
ONi
II
Primer
Extension
C
3 Xx
-9.6
-6.6
* -3.0
- 2.3
- 2.0
DNA gel blot
FIG. 2. (A) RNA gel blot of C protein RNA from the Xenopus A6
cell line. The size of the prominent RNA species hybridizing with
cloned C protein cDNA probe is =1.3 kb based on the position of
ribosomal RNA standards in adjacent lanes. Lane 1, Poly(A)+ RNA
fraction from 200 ,ug of total cellular RNA; lane 2, 25 ,tg of the
poly(A)-depleted fraction of A6 RNA. (B) Primer-extension using C
protein RNA as template. A 32P-end-labeled C protein primer was
hybridized with 25 ,g of total RNA from Xenopus liver, the primer
was extended by reverse transcriptase, and extension products were
displayed on a sequencing gel calibrated by a DNA sequence ladder
generated by extension of the same primer used in RNA analysis.
Lane 1, extension products; lane 2, G sequence ladder. (C) DNA gel
blot. The lanes labeled 1 and 3 are reconstruction standards con-
taining the equivalent of one and three copies of C protein cloned
DNA per haploid genome for a 5-,ug sample of Xenopus nuclear
DNA. Lane X contains 5 ,ug of Xenopus nuclear DNA digested with
Xba I.
Proc. Natl. Acad. Sci. USA 85 (1988)
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communication). This prevalence is typical of the majority of
maternal poly(A)+ RNAs in Xenopus stage-VI oocytes (44).
The 5' end of C protein mRNA has a long untranslated
leader that is represented in clone pXEC1.3, whereas
pXEC1.0 possesses a shorter 5'-untranslated segment. To
better define the 5' end of this RNA, a labeled primer was
hybridized with total liver RNA and extended with avian
myeloblastosis virus reverse transcriptase (Fig. 2B). A prom-
inent product 33 nt longer than pXEC1.3 was seen; this is
consistent with the mRNA length seen in the RNA gel blot
experiments and indicates that the 5'-untranslated segment is
=228 nt in length. This size constitutes a minimum length,
and definitive assignment of the transcription start will
require cloning and transcript mapping of genomic se-
quences.
One RNA Species Produces Two C Proteins. RNP prepara-
tions from mammalian cells contain two distinct C protein
species that can be resolved in SDS/polyacrylamide gels, and
these species occur in a relatively reproducible ratio of =1: 3,
with the more slowly migrating species present in lower
amounts. We investigated the synthesis ofXenopus C protein
from defined cloned mRNAs transcribed in vitro by SP6
polymerase. These were translated in rabbit reticulocyte
extracts and in Xenopus oocytes. RNA transcribed from
pXEC1.3 contains the long 195-nt 5'-untranslated segment,
and in both translation systems this RNA produced two
polypeptide species that migrate with apparent molecular
masses of 41 and 39 kDa in a ratio similar to in vivo RNP
preparations from mammalian cells (Fig. 3 A and B). Sur-
prisingly, only the 39-kDa product is produced when the
shorter pXEC1.0 RNA is the template (Fig. 3B). As the two
RNAs differ only in the lengths of their 5'-untranslated
sequences, it seems unlikely that the protein species arise
from some posttranslational modification. Although it is
formally possible that the 41-kDa product could initiate from
an upstream methionine shifted into frame by an SP6 tran-
scription error, a more attractive alternative is that the two
protein species are produced by the use of more than one
initiation codon in the major open reading frame (methionine
1 or 2 versus methionine 15, for example). If this explanation
is correct, it suggests that the mechanism by which the
initiation choice is made must depend, at least in part, on the
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FIG. 3. (A) In vivo translation and subcellular localization pro-
teins produced from SP6-transcribed C protein mRNA. Individual
oocytes were dissected as indicated and displayed on an SDS/
polyacrylamide gel. Nuclear and cytoplasmic fractions from a second
independent experiment are shown at right. (B) In vitro translation
of two species of C protein SP6 RNAs generated from clones with
differing 5'-untranslated segments. RNAs containing either pXEC1.O
or pXEC1.3 cDNA inserts were produced using SP6 polymerase in
vitro and then translated in a rabbit reticulocyte lysate containing
[35S]methionine. The labeled products are displayed on an
SDS/polyacrylamide gel as indicated. pXEC1.O contains a truncated
5'-untranslated region beginning at nucleotide 141 of the sequence in
Fig. 1.
5'-untranslated leader. Furthermore, the choice is made
similarly, both quantitatively and qualitatively, in frog
oocytes and rabbit reticulocyte lysates. This choice is prob-
ably not a peculiarity of the Xenopus gene because C protein
RNA prepared by hybrid selection from cultured human cells
was recently shown to produce both C1 and C2 in a
reticulocyte translation system (43). The nature of the dif-
ference between C1 and C2 proteins and the molecular
mechanism by which it is generated should be decisively
resolved by direct protein sequence determinations together
with site-directed mutagenesis of 5'-untranslated sequences
and proposed initiation codons.
Nuclear Localization. In mammalian somatic cells RNP
proteins are localized in the nuclei 'of interphase cells. To
examine the subcellular localizatiop of C protein in Xenopus
oocytes, the cDNA sequences were inserted into the bacte-
riophage RNA polymerase vector pSP65. Capped RNA was
transcribed by SP6 polymerase, and the RNA was microin-
jected into the cytoplasm of stage-VI Xenopus oocytes.
Newly synthesized proteins were labeled by incubating the
oocytes in [35S]methionine. The distribution of labeled C
protein was measured by dissecting oocytes into cytoplasmic
and nuclear fractions and subjecting the samples to SDS gel
electrophoresis (Fig. 3A). In most experiments 80-95% of
both newly synthesized C protein species were in the ger-
minal vesicle fraction after 4-20 hr of labeling. The nucleus
composes =412% of the oocyte volume (excluding yolk
platelets), so the observed distribution of C protein corre-
sponds to a 7- to 18-fold concentration in the nuclear
compartment. Other newly synthesized proteins encoded by
endogenous and heterologous RNAs for nonnuclear proteins
are not localized in the germinal vesicle (Fig. 3 and B.W.,
unpublished data). The data presented here do not provide a
direct measure of the kinetics of import into the nucleus, but
the shortest labeling periods showed accumulation of >85%
of both C protein species within 4 hr, suggesting that import
is quite rapid.
A characteristic of some rapidly accumulated nuclear
proteins is the presence of one or more copies of a small
nuclear localization sequence (for review see ref. 45). A
search of the Xenopus C protein revealed one candidate
sequence beginning at residue 141, Pro-Ser-Lys-Arg-
Gln-Arg-Val, that is a 5/7 match with the consensus simian
virus 40 large tumor antigen nuclear localization tag (46) and
also resembles related sequences in the nuclear localization
region of Xenopus nucleoplasmin (47). Although this se-
quence appears to be a good candidate for the nuclear target
sequence (differences from tested sites are conservative or
appear at the most flexible residue), its physiological signif-
icance remains to be determined.
C Protein Sequences in the Genome. Mammalian genomes
contain numerous sequences that hybridize with the human
C protein clone (32), and by analogy with genomic cloning
data for other human RNPs, it seems likely that many C
protein sequences will turn out to be pseudogenes (C.
Morandi, personal communication). In contrast to the mam-
malian data, gel blots of DNA from a single frog show a
simple pattern of one-to-three fragments with different re-
striction enzyme digests. Comparison with known copy-
number standards (Fig. 2C) and the results of screening frog
genomic libraries all indicate that the Xenopus genome
contains a very small number of C protein genes-probably
only two or three per haploid genome. Reducing the hybrid-
ization and filter-washing stringencies by 10°C failed to
identify any new Xenopus DNA fragments that would indi-
cate divergent but related genes.
C Protein Structure. Several features of the Xenopus C
protein sequence are of interest with respect to its interaction
with RNA, its possible contributions to RNP assembly and
architecture, and its localization in the nucleus. Three po-
Genetics: Preugschat and Wold
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tential domains can be identified, and these domains are
noted in Fig. 4. The amino-terminal domain of =90 residues
shares with other RNA-binding proteins a similar array of
aromatic residues as well as a specific octapeptide sequence
that has been found in virtually all nuclear RNA-binding
proteins for which sequence information is available. The
octapeptide was first noted in mammalian A protein sequence
(49) and has been postulated to mediate binding of yeast
poly(A) binding protein with poly(A) (50). The occurrence of
this hallmark feature in several different RNP proteins from
phylogenetically diverse organisms is summarized in Table 1.
The consensus octapeptide includes three aromatic residues
that might be expected to interact with RNA by intercalating
between bases, whereas nearby positively charged residues
would be expected to facilitate binding by countering nega-
tive charges on the nucleic acid phosphate backbone. RNA
binding has not yet been directly demonstrated for the
amino-terminal domain of C protein, but similar 90- to
100-residue domains of other RNP proteins have been shown
to bind single-strand nucleic acids in vitro (2, 62).
The presence of the octapeptide sequence in diverse
RNA-binding proteins together with the potential nucleic
acidbinding character of the sequence itself, suggest that the
sequence plays a role in RNA-protein interactions. How-
ever, the motif of aromatic amino acids with a nearby basic
residue is not confined to the conserved sequence and also
appears at several other points (arrows in Fig. 4, domain I)
within the larger 90-100-amino acid "RNA domains" of each
of these RNP proteins. The positions of the additional
basic-aromatic elements are similar in other RNP proteins.
This raises the possibility that the RNA-binding character of
these domains is distributed among the several basic-
aromatic elements, rather than being localized within the
octapeptide region. In support of this possibility, the first
mutational studies of yeast poly(A)-binding protein show that
neither mutation of conserved aromatic residues within the
octapeptide nor deletion of the entire octapeptide eliminates
RNA binding in vitro or the capacity to complement a
poly(A)-binding protein-deficient strain in vivo (62).
A distinction between the proposed RNA-binding domain
of C protein and that of all other such domains identified to
date is its net charge. C protein is acidic overall, but this is
entirely due to the concentration of aspartic and glutamic acid
residues in the hydrophilic carboxyl-terminal domain. The
amino-terminal RNA domain alone is, in fact, highly basic
with basic-to-acidic content of 12:4. It seems possible that
this local positive charge facilitates RNA binding, and this
charge may contribute to the comparatively tight RNA
binding that characterizes C proteins relative to A and B
proteins (9). The A protein RNA domains, for example, are
much less basic with basic-to-acidic content of 13:13 and
11: 9 (55). The proposed middle domain is distinctive among
FIG. 4. C protein hydropathy plot and sequence features. The
hydropathy values of Kyte and Doolittle (48) were used with a
window of seven. The protein domains I-III discussed in the text are
indicated. Vertical arrows mark aromatic residues. m, Potential type
II casein kinase phosphorylation sites; c, potential nuclear localiza-
tion tag. The proposed RNP consensus octamer is indicated by dark
shading of the hydropathy profile.
Table 1. RNA-binding protein homology
Organism Amino
Protein (ref.) acid Sequence
Poly(A)-binding Yeast (50, 51) 78-93 SLGYAVNFNDHEAGRK
protein 165-180 SKGFGFVHFEEEGAAK
258-273 LKGFGFVNYEKHEDAV
361-376 SKGFGFVCFSTPEEAT
Human (52) 51-66 SLGYAYVNFQQPADAE
137-152 SKGYGFVHFETQEAAE
227-242 SKGFGFVSFERHEDAQ
329-344 SKGFGFVCFSSPEEAT
SSB-1 Yeast (53) 234-249 NRGMAFVTFSGENVDI
Nucleolin Hamster (54) 346-361 NRKFGYVDFESAEDLE
428-443 SKGIAYIEFKSEADAE
521-536 SKGYAFIEFASFEDAK
608-623 SKGFGFVAFNSEEDAK
UPi Calf (49) 53-68 SRGFGFVTYATVEEVD
144-159 KRGFAFVTFDDHDSVD
A1/hnRNP Rat and 54-69 SRGFGFVTYATVEEVD
human (55, 145-160 KRGFAFVTFDDHDSVD
56)
UP2/hnRNP? Human (57) 212-225 RRGFCFITFNQEEP
C/hnRNP Human (43) 49-64 HKGFAFVQYVNERNAR
Frog (Fig. 1) 50-65 HKGFAFVQFSNERTAR
U1 snRNP 70 kDa Human (58) 320-335 PRGYAFIEYEHERDMH
U2 snRNPB" Human (59) 48-63 MRGQAFVIFKELSSTN
U1 snRNPA Human (60) 51-66 MRGQAFVIFKEVSSAT
P9 Fly (61) 71-86 SRGFGFITYSHSSMID
163-178 KRGFAFVEFDDYDPVD
Core consensus KGFGFVXF
Frequent changes R YAYI Y
RNA-binding proteins characterized to date. The middle
domain is basic but lacks an RNP consensus.
The carboxyl-terminal domain of C protein is strikingly
different from the first two and is responsible for the acidic
character of the protein. This conforms to the general
organization of other nuclear RNA-binding proteins in which
the putative ancestral RNA-binding domain(s) are at the
amino terminus, whereas distinctive, protein-specific do-
mains are located at the carboxyl terminus. The proposed
third domain of C protein is 100 amino acids in length and
contains 39 acidic residues, 13 basic residues, and no aro-
matic amino acids. Moreover, three of four potential sites for
phosphorylation by a casein type II kinase activity (63) are
located in the third domain at Ser-240, Thr-256, and Thr-267.
It is known that mammalian C proteins are phosphorylated in
vivo and are substrates in vitro for a type II casein kinase (64,
65). These posttranslational modifications would further
increase the negative charge in the carboxyl-terminal do-
main, and they present the obvious possibility of regulating
function.
The carboxyl-terminal domains of the RNPs have been
postulated to mediate protein-protein interactions (for re-
view, see ref. 2). The C protein carboxyl-terminal domain is
hydrophilic and acidic. Although these properties contrast
sharply with the analogous domains of other core RNP
proteins, such properties are reminiscent of anotherXenopus
nuclear protein, nucleoplasmin (47). Nucleoplasmin facili-
tates nucleosome assembly (66, 67), apparently by neutral-
izing positive charge on core histones. This structural simi-
larity between nucleoplasmin and C protein makes it inter-
esting to consider a potential functional analogy in which C
protein may play a role in ribonucleosome or spliceosome
assembly by neutralizing basic proteins such as the A and B
core hnRNPs. In this case, however, C protein would remain
as a component of the ribonucleosome, whereas nucleoplas-
min does not remain as part of the assembled nucleosome.
Proc. Natl. Acad. Sci. USA 85 (1988)
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The availability of cloned cDNAs coding for several
nuclear RNA-binding proteins [poly(A)-binding protein of
yeast (50, 51) and Xenopus (R. Moon, unpublished work), A
protein of rat (55) and Xenopus (D. Ruff and B.W., unpub-
lished data), and C protein of human (43) and Xenopus]
should now permit decisive tests for the function of different
RNP domains and of explicit features within a domain.
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